Market Closed -
Other stock markets
|
After market 04:59:58 pm | |||
69.18 EUR | -1.31% | 69.25 | +0.10% |
09:13am | AKZO NOBEL NV : JP Morgan remains a Sell rating | ZD |
Mar. 14 | AKZONOBEL : Another challenging year, but with somewhat higher profitability |
Sales 2024 * | 10.75B 11.59B | Sales 2025 * | 11.08B 11.94B | Capitalization | 11.96B 12.89B |
---|---|---|---|---|---|
Net income 2024 * | 645M 695M | Net income 2025 * | 757M 816M | EV / Sales 2024 * | 1.45 x |
Net Debt 2024 * | 3.62B 3.9B | Net Debt 2025 * | 3.24B 3.49B | EV / Sales 2025 * | 1.37 x |
P/E ratio 2024 * |
18.5
x | P/E ratio 2025 * |
15.8
x | Employees | 34,760 |
Yield 2024 * |
2.88% | Yield 2025 * |
3% | Free-Float | 98.45% |
Latest transcript on Akzo Nobel N.V.
1 day | -0.97% | ||
1 week | +3.77% | ||
Current month | +3.09% | ||
1 month | +1.94% | ||
3 months | -7.34% | ||
6 months | +2.60% | ||
Current year | -7.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 22-10-31 | |
Maarten de Vries
DFI | Director of Finance/CFO | 62 | 17-12-31 |
Kenny Chae
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Byron Grote
BRD | Director/Board Member | 76 | 14-04-28 |
Pamela Kirby
BRD | Director/Board Member | 70 | 16-04-19 |
Ben Noteboom
CHM | Chairman | 65 | 23-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.73% | 293 M€ | +12.24% | ||
1.22% | 2 M€ | -3.47% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 69.18 | -1.31% | 321 731 |
24-03-27 | 70.1 | +1.77% | 384,105 |
24-03-26 | 68.88 | +1.98% | 507,402 |
24-03-25 | 67.54 | +1.44% | 449,328 |
24-03-22 | 66.58 | -0.48% | 280,868 |
Real-time Euronext Amsterdam, March 28, 2024 at 05:52 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.22% | 12.94B | |
+11.22% | 88.14B | |
-3.35% | 34B | |
-16.30% | 32.58B | |
-4.87% | 17.21B | |
-5.01% | 7.94B | |
+0.91% | 7.55B | |
-10.40% | 3.06B | |
-21.15% | 2.57B | |
-30.79% | 2.4B |